Indexa Capital plans to start trading on the BME Growth in mid-July, since it has already submitted the necessary documentation and is only waiting for the manager of the Spanish stock markets and markets to approve the operation.

The IPO will take place through a direct ‘listing’. In other words, Indexa Capital will start trading without carrying out a capital increase and without placing new shares on the market. Once admitted to trading, any person may place buy or sell orders.

“The negotiation in the BME Growth segment will provide the company with additional visibility and trust with its clients, strengthening its relations with public bodies, financing agents, clients and suppliers”, the CEO of Indexa Capital Group explained to Europa Press. , Unai Advise.

Among the other objectives of Indexa are to offer greater liquidity to its shareholders who wish to sell part of their shares and greater ease of investment to investors who wish to buy shares, as well as achieving greater financing capacity and flexibility with a lower cost of capital facing, mainly, inorganic growth.

As a prior step for its IPO, the company decided in May to appoint Almudena Sainz de la Cuesta Abbad and Sol Fernández-Rañada López-Doriga as independent directors.

Both directors have become part of the company’s audit and accounts committee. Thus, the board of directors is set at six people, with the executive directors François Derbaix, Ramón Blanco and Unai Ansejo Barra, together with the proprietary director José Martín Cabiedes, representing Cabiedes

The company is one of the benchmarks for indexed and automated investment (roboadvisors) in Spain. It has a portfolio of 64,000 clients and more than 1,710 million euros in assets under management. Most of that figure is allocated to index fund portfolios (1,430 million). The rest is distributed between pension plans and a fund of funds.

In addition, the management team itself and the partners have more than 32 million euros in Indexa’s portfolios.